
iMatrix
Founded Year
2002Stage
Acquired | AcquiredAbout iMatrix
iMatrix provides digital marketing solutions for healthcare professionals in the eye care, chiropractic, and veterinary industries. The company's products are Chiromatrix and Vetmatrix. It was founded in 2002 and is based in San Diego, California. In January 2014, Internet Brands acquired iMatrix. The terms of the transaction were not disclosed.
Missing: iMatrix's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: iMatrix's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
iMatrix Patents
iMatrix has filed 6 patents.
The 3 most popular patent topics include:
- Integers
- Spamming
- Algebraic graph theory

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
11/28/2016 | 3/22/2022 | Natural language processing, Email, Machine learning, Computational linguistics, Spamming | Grant |
Application Date | 11/28/2016 |
---|---|
Grant Date | 3/22/2022 |
Title | |
Related Topics | Natural language processing, Email, Machine learning, Computational linguistics, Spamming |
Status | Grant |
Latest iMatrix News
Sep 5, 2022
Designed to efficiently induce differentiation in ES and iPS cells, AMSBIO has expanded its iMatrix series of recombinant laminin E8 fragments to now include laminin isoforms LN-111 and LN-332. This expanded range of laminin isoforms (LN-111, 332, 511, 411 and 221) now provides even greater flexibility and control when tailoring your substrate to the requirements of specific cultured cells. Proven in many leading life science research labs – iMatrix is used as a substrate for culturing and maintaining cells, including Pluripotent Stem Cells and Mesenchymal Stem Cells, as well as for differentiation into ectoderm, endoderm, and mesoderm. All iMatrix products offer the dual advantage of recombinant protein expression and as E8 fragments they contain all of the integrin-binding sites of full-length laminin in a much shorter protein. New to the product range, iMatrix-111 is the E8 fragment of the LN-111 laminin isoform, which plays significant roles in vivo and is important in cell culture. As well as being the major substrate for nerve axon growth, both in vivo and in vitro, LN-111 is also the main component of the industry standard substrates used in cell culture: Matrigel and Cultrex BME. iMatrix-111 has been validated for to promote differentiation of iPSCs into hepatocyte-like cells. The Laminin-332 isoform is essential for epithelial cell adhesion to the basement membrane and iMatrix Laminin-322 has been used to induce differentiation of iPS cells into corneal epithelial cells in vitro . Featured Image: ACE2-expressing iPS cells grown with iMatrix-511 as ECM in StemFit medium; infected with SARS-CoV-2 virus after cryopreservation in STEM CELLBANKER. Green: SARS-CoV-2 N protein, Red: OCT3/4, Blue: DAPI. Photo: Courtesy of Kazuo Takayama (CiRA, Kyoto University, Japan) Share:
iMatrix Frequently Asked Questions (FAQ)
When was iMatrix founded?
iMatrix was founded in 2002.
Where is iMatrix's headquarters?
iMatrix's headquarters is located at 5550 Morehouse Drive, San Diego.
What is iMatrix's latest funding round?
iMatrix's latest funding round is Acquired.
Who are the investors of iMatrix?
Investors of iMatrix include Internet Brands.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.